The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease.
Klein
C
C
Internal Medicine Cardiology, Charité, Humboldt University, Berlin, Germany. c.klein@lrz.tu-muenchen.de
Nagel
E
E
Schnackenburg
B
B
Bornstedt
A
A
Schalla
S
S
Hoffmann
V
V
Lehning
A
A
Fleck
E
E
D003287:Contrast Media; D003327:Coronary Disease / Q000175:diagnosis*; D003911:Dextrans; D052203:Ferrosoferric Oxide; D006801:Humans; D007091:Image Processing, Computer-Assisted / Q000379:methods; D007501:Iron; D018810:Magnetic Resonance Angiography / Q000379:methods*; D058185:Magnetite Nanoparticles; D010087:Oxides
D003287:Contrast Media; D003911:Dextrans; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; D007501:Iron; D052203:Ferrosoferric Oxide